2019 Breakthrough Summit Co-Host Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Stock and Other Patents, Royalties, Travel, Speakers' Expert Name Employment Leadership Ownership Honoraria Consulting or Advisory Role Research Funding Other Intellectual Accommodations, Other Bureau Testimony Interests Property Expenses Dae Ho Lee Abbvie, AstraZeneca/MedImmune, Boehringer ST Cube Ingelheim, Bristol-Myers Squibb, Chong Kun Dang Pharmaceutical, CJ Healthcare, Janssen, Lilly, Merck, MSD, Mundipharma, Novartis, Ono Pharmaceutical, Pfizer, Roche/Genentech, Samyang, ST Cube, Takeda Ekaphop Amgen, AstraZeneca, Boehringer Ingelheim, Bristol- AstraZeneca, MSD, Sirachainan Myers Squibb, Diethelm Keller Logistics, LF Asia, Pfizer Merck, MSD, Mundipharma, Roche, Sanofi/Aventis Lillian L. Siu Agios (I) Agios (I) AstraZeneca/MedImmune, Loxo, Merck, Amgen (Inst), Astellas Pharma (Inst), AstraZeneca (Inst), Bayer (Inst), MorphoSys, Roche, Symphony Evolution Boehringer Ingelheim (Inst), Bristol-Myers Squibb (Inst), Genentech/Roche (Inst), GlaxoSmithKline (Inst), MedImmune (Inst), Merck (Inst), Novartis (Inst), Pfizer (Inst), Symphony Evolution (Inst) Virote Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Amgen, AstraZeneca, Boehringer Ingelheim, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Lilly, Amgen, AstraZeneca, Sriuranpong Bristol-Myers Squibb, Eisai, Lilly, MSD Oncology, Eisai, MSD Oncology, Novartis, Roche MSD Oncology, Novartis, Pfizer, Roche, Taiho Pharmaceutical Eisai, MSD Oncology, Novartis, Pfizer, Roche, Taiho Pharmaceutical Sanofi Peter P. Yu Apple, Contrafect, Google, IBM, Microsoft, Oracle Corporation 2019 Breakthrough Summit Organizing Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Stock and Other Patents, Royalties, Travel, Speakers' Expert Name Employment Leadership Ownership Honoraria Consulting or Advisory Role Research Funding Other Intellectual Accommodations, Other Bureau Testimony Interests Property Expenses Frances M. Pfizer Lilly, Novartis, Pfizer, Roche, Roche/Genentech Novartis Novartis, Pfizer Breast Cancer Boyle Network of Australia, Clinical Oncology Society of Australia, Pam McLean Communications Centre, Paxman Chikashi Asahi Kasei, AstraZeneca, Bayer, Chugai Pharma, Asahi Kasei (Inst), Astellas Pharma (Inst), AstraZeneca (Inst), Bayer Ishioka Daiichi Sankyo, Eisai, Lilly Japan, Merck Serono, (Inst), Bristol-Myers Squibb (Inst), Chugai Pharma (Inst), Daiichi Mochida Pharmaceutical Co. Ltd., Nihonkayaku, Sankyo (Inst), Eisai (Inst), Kissei Pharmaceutical (Inst), Kyowa Hakko Nipro Corporation, Novartis, Ono Pharmaceutical, Kirin (Inst), Lilly Japan (Inst), Merck Serono (Inst), Mochida Sanofi, Taiho Pharmaceutical, Takeda, Yakult Pharmaceutical Co. Ltd. (Inst), MSD K.K (Inst), Nihonkayaku (Inst), Honsha Novartis (Inst), Ono Pharmaceutical (Inst), Taiho Pharmaceutical (Inst), Takeda (Inst), Tsumura & Co. (Inst), Yakult Honsha (Inst) Yuko Asahi Kasei, Chugai Pharma, Ethicon, Nippon Ajinomoto (Inst), Asahi Kasei (Inst), Astellas Pharma (Inst), Boehringer Kitagawa Kayaku, Olympus, Ono Pharmaceutical, Taiho Ingelheim (Inst), Chugai Pharma (Inst), CSL Behring (Inst), Daiichi Pharmaceutical Sankyo (Inst), Dainippon Sumitomo Pharma (Inst), EA Pharma (Inst), GlaxoSmithKline (Inst), Kaken Pharmaceutical (Inst), Kowa (Inst), Kureha (Inst), Kyowa Hakko Kirin (Inst), Lilly (Inst), Medicon (Inst), Medtronic (Inst), Merck Serono (Inst), Nippon Kayaku (Inst), Novartis (Inst), Otsuka (Inst), Pfizer (Inst), Sanofi (Inst), Shionogi (Inst), Taiho Pharmaceutical (Inst), Taisho Toyama Pharma (Inst), Takeda (Inst), Teijin Pharma (Inst), Tsumura & Co. (Inst), Yakult Honsha (Inst) Herbert H. GlaxoSmithKline, Novartis, Roche/Genentech Abbvie, MSD Oncology (Inst) Bayer, MSD Oncology, Loong Ignyta, Pfizer, Roche Novartis Gilberto Lopes Pfizer AstraZeneca (Inst), AstraZeneca, Bavarian Nordic (Inst), Blueprint Medicines (Inst), EMD Serono (Inst), G1 Therapeutics (Inst), Merck Sharp & Dohme (Inst), Novartis (Inst), Tesaro (Inst) Yeon Hee Merck, Novartis, Pfizer Pfizer AstraZeneca, Eisai, Pfizer Merck, Novartis Park Naiyarat AstraZeneca, Boehringer Ingelheim, Novartis, AstraZeneca Prasongsook Roche Roche Buenaventura C. Ramos Ying Wang Rui-hua Xu Yun Yen Fulgent Diagnostics 2019 Breakthrough Summit Program Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Stock and Other Patents, Royalties, Travel, Speakers' Expert Name Employment Leadership Ownership Honoraria Consulting or Advisory Role Research Funding Other Intellectual Accommodations, Other Bureau Testimony Interests Property Expenses Yung-Jue Astellas Pharma, AstraZeneca/MedImmune, Astellas Pharma (Inst), AstraZeneca/MedImmune (Inst), Bayer (Inst), Bang Bayer, BeiGene, Bristol-Myers Squibb, Daiichi BeiGene (Inst), Boehringer Ingelheim (Inst), Boston Biomedical (Inst), Sankyo, Genentech/Roche, Genexine, Green Bristol-Myers Squibb (Inst), CKD (Inst), Curis (Inst), Daiichi Sankyo Cross, Hanmi, Lilly, Merck Serono, MSD (Inst), Five Prime Therapeutics (Inst), Genentech/Roche (Inst), Oncology, Novartis, Samyang, Taiho Genexine (Inst), GlaxoSmithKline (Inst), Green Cross Corp. (Inst), Lilly Pharmaceutical (Inst), Macrogenics (Inst), Merck Serono (Inst), MSD (Inst), Novartis (Inst), Ono Pharmaceutical (Inst), Pfizer (Inst), Taiho Pharmaceutical (Inst), Takeda (Inst) Johanna C. Amgen (Inst), Apexigen (Inst), Arch Oncology Abbott/AbbVie (Inst), Acerta Pharma (Inst), ADC Therapeutics (Inst), ARMO BioSciences, Bendell (Inst), ARMO BioSciences (Inst), Array Agios (Inst), Amgen (Inst), Apexigen (Inst), Arch Oncology (Inst), Boehringer Ingelheim, BioPharma (Inst), AstraZeneca (Inst), Bayer ARMO BioSciences (Inst), Array BioPharma (Inst), Arrys (Inst), Bristol-Myers Squibb, (Inst), Beigene (Inst), Boehringer Ingelheim (Inst), AstraZeneca/MedImmune (Inst) ,Bayer (Inst), BeiGene (Inst), Blueprint Celgene, Daiichi Bristol-Myers Squibb (Inst), Celgene (Inst), Medicines (Inst), Boehringer Ingelheim (Inst), Boston Biomedical (Inst), Sankyo, FORMA Cerulean Pharma (Inst), Continuum Clinical Bristol-Myers Squibb (Inst), Calithera Biosciences (Inst), Celgene Therapeutics, Gilead (Inst), Cyteir (Inst), Daiichi Sankyo (Inst), EMD (Inst), Celldex (Inst), Cyteir (Inst), CytomX Therapeutics (Inst), Daiichi Sciences, Ipsen, Lilly, Serono (Inst), Five Prime Therapeutics (Inst), Sankyo (Inst), eFFECTOR Therapeutics (Inst), Eisai (Inst), EMD MedImmune, Merck, FORMA Therapeutics (Inst), Genentech/Roche Serono (Inst), Evelo Therapeutics (Inst), Five Prime Therapeutics Novartis, OncoMed, (Inst), Gilead Sciences (Inst), GlaxoSmithKline (Inst), FORMA Therapeutics (Inst), Forty Seven (Inst), Roche/Genentech, (Inst), Incyte (Inst), Innate Pharma (Inst), Ipsen Genentech/Roche (Inst), Gilead Sciences (Inst), GlaxoSmithKline Taiho Pharmaceutical (Inst), Janssen (Inst), Leap Therapeutics (Inst), (Inst), Gritstone Oncology (Inst), Harpoon therapeutics (Inst), ImClone Lilly (Inst), Macrogenics (Inst), MedImmune (Inst), Systems (Inst), Incyte (Inst), Innate Pharma (Inst), Ipsen (Inst), Jacobio Merck (Inst), Merrimack (Inst), Moderna (Inst), Janssen (Inst), Kolltan Pharmaceuticals (Inst), Leap Therapeutics (Inst), Molecular Partners (Inst), Therapeutics (Inst), Lilly (Inst), Macrogenics (Inst), Marshall Edwards Novartis (Inst), Oncogenex (Inst), OncoMed (Inst), (Inst), Merck (Inst), Merrimack (Inst), Mersana (Inst), Merus (Inst), Phoenix Biotech (Inst), Prelude Therapeutics Millenium Pharamceuticals (Inst), Molecular Partners (Inst), Nektar (Inst), Sanofi (Inst), Seattle Genetics (Inst), Taiho (Inst), Novartis (Inst), Novocure (Inst), Oncogenex (Inst), OncoMed Pharmaceutical (Inst), Tanabe Research (Inst), (Inst), Onyx (Inst), Pfizer (Inst), Phoenix Biotech (Inst), Pieris TD2 (Inst), TG Therapeutics (Inst), Tizona Pharmaceuticals (Inst), Prelude Therapeutics (Inst), Rgenix (Inst), Therapeutics (Inst), Tolero Pharmaceuticals Sanofi (Inst), Sierra Oncology (Inst), Sorrento Therapeutics (Inst), (Inst), Torque (Inst) Stem CentRx (Inst), SynDevRx (Inst), Taiho Pharmaceutical (Inst), Takeda (Inst), Tarveda Therapeutics (Inst), TG Therapeutics (Inst), Tizona Therapeutics, Inc. (Inst), Torque (Inst), TRACON Pharma (Inst), Tyrogenex (Inst), Unum Therapeutics (Inst), Vyriad (Inst) Rebecca A. AstraZeneca, Lilly, Pfizer, Roche/Genentech AstraZeneca, Eisai, Merck, Novartis, Pfizer, Amgen, Merck, Pfizer, Dent Roche Roche Edward S. Kim AstraZeneca, Boehringer Ingelheim, Lilly, Merck, AstraZeneca, Boehringer Ingelheim, Lilly, Merck, Boehringer Ingelheim, Genentech/Roche, Ignyta, Lilly, Merck AstraZeneca, Pfizer, Takeda Pfizer, Takeda Boehringer Ingelheim, Genentech/Roche, Lilly, Takeda Jack Li Tony S. Mok The Chinese AstraZeneca, Hutchison ACEA Biosciences, AstraZeneca, Boehringer ACEA Biosciences, AstraZeneca, Boehringer AstraZeneca (Inst), Boehringer Ingelheim (Inst), Bristol-Myers Squibb University of Hutchison MediPharma, Ingelheim, Bristol-Myers Squibb, Celgene, Fishawack Ingelheim, Bristol-Myers Squibb, Celgene, Cirina, (Inst), Clovis Oncology (Inst), Merck Sharp & Dohme (Inst), Novartis Hong Kong MediPharma, Sanomics Limited Facilitate Ltd, Hutchison MediPharma, Ignyta, Clovis Oncology, geneDecode, Hutchison (Inst), Pfizer (Inst), Roche (Inst), SFJ Pharmaceuticals Group (Inst), Sanomics Janssen,